Trial Supplies, IP Accountability and the Supply Chain

Part of Clinical Research Associate (CRA) Training: Data, Documentation and Trial Supplies.

About 6 minutes. Free, in your language, no account needed.

Why this matters

A site that runs out of investigational product cannot dose. A site that runs out of laboratory kits cannot collect the endpoint. Missing supplies cause missed visits, protocol deviations, delayed enrollment and, when the product is involved, safety risk.

Supply is the least glamorous area of monitoring and one of the most consequential.

What a site needs

Seven categories cover most trials.

1. Investigational product, and comparator or placebo.
2. Laboratory supplies and sampling kits — tubes, containers, needles, processing materials, labels, requisition forms and lab manuals.
3. Medical equipment and devices — vital signs monitors, electrocardiograph machines, spirometers, scales, infusion or injection devices, calibrated timers.
4. Study documentation and forms — printed protocol, Investigator's Brochure, manuals, visit checklists, paper worksheets and safety forms where used.
5. Participant materials — diaries, instruction leaflets, appointment cards, 24-hour emergency contact cards, educational material.
6. Packaging, labeling and shipping supplies — insulated containers, coolant, absorbent pads, biohazard bags, courier documentation, and compliant packaging for biological samples.
7. Technical supplies — ePRO devices, dedicated computers, scanners, secure connectivity.

Investigational product: what you verify

Supply level. Enough product on hand to cover enrolled participants and upcoming visits within the ordering and shipping lead time. Ask what the reorder trigger is and who watches it.

Storage. Required temperature range and light protection; secure, restricted access; clearly labeled and separated by strength or formulation; usable product segregated from quarantined and expired product.

Temperature records. Complete, legible and in range. Gaps are findings, because a gap means nobody can state what the temperature was. Check that an excursion procedure exists in writing and that staff know the out-of-hours route.

Accountability and reconciliation. Compare shipment records, receipt logs, dispensing logs, returns and destruction records. Reconcile by lot and, where applicable, by participant:

starting inventory + received − dispensed − returned − destroyed = physical count

Investigate every discrepancy. Small unexplained differences that recur are not administrative; they can indicate diversion.

Compliance. Verify pill counts or device usage against diary entries and visit data, and confirm poor adherence is documented and managed as the protocol requires.

Inventory management at the site

Good inventory practice shares the same principles whatever the tool.

• Accuracy — records match physical stock.
• Timeliness — updated at the time of receipt, dispensing, return or discard.
• Traceability — always clear what was used, for whom, when, and by whom.
• Visibility — authorized staff can see stock levels and expiry dates.
• Forecasting — resupply is requested before stock becomes critical.

Sites track supplies on paper logs, spreadsheets, IRT systems, or central laboratory portals. Whatever the tool, ask three questions: who is responsible, how often is stock reviewed, and how is the decision to reorder made. A site with no named owner for supplies will eventually run out.

Expiry management. Kits and product expire. Encourage first-expire-first-out rotation, a regular review of items expiring in the next one to two months, and immediate segregation and labeling of expired stock.

Forecasting uses current enrollment, projected enrollment, the visit schedule, average usage per participant, shipping lead time, and a buffer. Help sites do this arithmetic rather than assuming they have.

The supply chain, and where it fails

Supplies move through manufacturing and packaging, central depots and regional warehouses, transport to sites, on-site storage and use, and finally return or destruction.

The recurring failures:

• Shipping delays and lost shipments, from courier problems, weather, incorrect shipping details or regional holidays.
• Customs and import barriers, from incomplete documentation, changing requirements, or additional review of controlled substances, biologics or temperature-sensitive materials.
• Temperature excursions and cold chain failure, from refrigeration faults, inadequate packaging, poor handling, or transit exceeding validated durations.
• Forecasting errors and shortages, when enrollment moves faster than planned or visits cluster.
• Expiry, particularly in long studies where lots approach expiry while still needed.
• Vendor or regulatory change mid-study, requiring new processes and training.

Early warning signs

• The site repeatedly says it is nearly out of product or kits.
• Shipments are routinely late.
• Visits are being rescheduled for supply reasons.
• Repeated temperature excursions in transit.
• Short-dated lots arriving close to expiry.
• The central laboratory reports improperly packed or delayed samples.
• IRT records disagree with physical stock.

Across several visits or several sites, these indicate a system-level problem needing sponsor attention rather than a site problem.

What a CRA does

• Ask about stock levels at every visit and between visits when enrollment is rising.
• Confirm the site knows exactly who to contact for supply issues and what information to provide.
• Document supply problems in monitoring reports and issue trackers: what the issue is, which participants or visits are affected, and any deadline at risk.
• Escalate early, so the sponsor can arrange emergency shipments, alternative routes, or reprioritize between sites.
• On an excursion, confirm the site quarantined the affected supplies, documented the incident with dates, times and temperature records, and contacted the sponsor; then confirm the sponsor's disposition decision reached the site and that quarantined material is clearly marked and not dispensed.
• Pass site feedback upward: confusing labels, hard-to-open packaging, unreliable courier pickups. Over time this reduces the problem at source.

In practice

At a VT-301 site, Leah reviews the product fridge and finds a two-day gap in the temperature log over a public holiday weekend.

The coordinator says the fridge was certainly fine because nothing alarmed. Leah asks who would have heard the alarm. Nobody was in the building.

There is no evidence of an excursion and no evidence against one. That is exactly the problem: the record cannot demonstrate storage conditions for those two days.

She documents it as a major finding, confirms the site quarantines the affected lots pending the sponsor's assessment, and escalates. The sponsor evaluates and releases the product, but the process took a week and two participants' visits had to be rescheduled.

The corrective action is a continuous electronic temperature logger with a remote alarm, and a written out-of-hours escalation procedure with a named contact.

"Nothing alarmed" is not a temperature record. The log is the record.

Key takeaways

• Gaps in a temperature log are findings in themselves, because they mean the site cannot state what the storage conditions were.
• Product reconciliation compares shipment, receipt, dispensing, returns and destruction against a physical count, by lot and where applicable by participant, and recurring unexplained discrepancies can indicate diversion.
• Good inventory practice requires a named owner, timely records, visible expiry dates and forecasting from enrollment, visit schedule, usage and shipping lead time.
• Supply chain failures recur as shipping delays, customs barriers, cold chain failures, forecasting errors, expiry and vendor changes, and patterns across sites indicate a system-level problem.
• On a temperature excursion the CRA confirms quarantine, documentation and sponsor notification, then confirms the disposition decision reached the site and that quarantined material is marked and not dispensed.